Collaboration to accelerate genomics innovation in Japan

May 16, 2025 | Friday | News

MoU between Illumina and the OIST aims to converge cutting-edge genomics technologies with interdisciplinary science

image credit- shutterstock

image credit- shutterstock

US-based Illumina, a global leader in DNA sequencing and array-based technologies, and the Okinawa Institute of Science and Technology (OIST), an international graduate university in Okinawa, Japan, have announced a Memorandum of Understanding (MoU) to accelerate genomics innovation in alignment with the One World, One Health framework, which recognises the interconnectedness of human, animal, and environmental health.

This collaboration will combine Illumina's Next-Generation Sequencing (NGS) technologies and OIST's expertise in multidisplinary science from engineering, physics to biology, ecology and marine sciences. Together, the aim is to foster knowledge sharing, testing and evaluating cutting-edge technologies, facilitate technology disclosures, promote talent development, and collaboration on innovation events.

Through this partnership, Illumina and OIST aspire to become a knowledge hub that amplifies the potential of industry-academia collaboration and accelerates the advancement of genomic science in Japan.

One aim of the MoU is to accelerate access to genomics in Japan by becoming an epicentre of knowledge that draws on the capabilities of industry, academia, and the public sector.

An area of collaboration that is showing initial promise is in marine conservation using metagenomics, where environmental DNA (eDNA) is extracted from the ocean and sequenced to identify marine species.

 

Sign up for the editor pick and get articles like this delivered right to your inbox.

+Country Code-Phone Number(xxx-xxxxxxx)

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls